At the pharmaceutical industry’s first trade fair of 2025, SÜDPACK MEDICA anticipates strong interest in its sustainable packaging solutions. The star of the show will undoubtedly be PharmaGuard. This recyclable mono-material solution, which recently impressed the esteemed jury at the Packaging Innovation Awards with its design, performance, and sustainability, represents a significant step toward climate protection in the pharmaceutical industry and a major contribution to the circular economy. In addition, SÜDPACK MEDICA will showcase its new standard pouch range from the Coulmer plant, where the production area is currently being expanded, and extremely low-particle pouch-making material is produced in an ISO7 cleanroom environment.
Greater confidence in decision-making thanks to certified sustainability
Unlike conventional blister solutions, this innovative packaging concept for solid orally administered medications can be integrated into existing mechanical recycling streams, as it is primarily based on the polymer polypropylene. “PP inherently has a lower carbon footprint than composite materials like aluminum and PET, making PharmaGuard stand out with its significantly reduced climate impact (in CO2-eq.) as well as lower energy and water consumption,” confirms Thomas Freis, Managing Director of SÜDPACK MEDICA.
Recognizing the significance of resource consumption in film production, further processing, and various end-of-life (EoL) scenarios for the ecological footprint of packaging solutions, these factors were a central focus of the recent ISO 14040/44-verified Life Cycle Assessment (LCA) conducted by Sphera. The findings show that one square meter of PharmaGuard film, consisting of a 300-µm bottom film and a 90-µm top film, generates 1.54 kg of CO2-eq. across all stages of the value chain – from production, printing, and slitting to final processing and disposal.
Switching from the German electricity mix to hydropower can reduce CO2-eq. emissions by more than 15%. The EoL assessment assumed a standard EU recycling mix. If the material is mechanically recycled, emissions can be reduced by more than 20%. In the case of end-of-life chemical recycling, CO2-eq. emissions remain virtually unchanged compared to the baseline. However, this method offers the advantage that chemically recycled films can be reused as a raw material for new blister production, keeping them within the circular economy. The worst option is incineration, which is still widely practiced: If the material is burned rather than recycled, CO2-eq. emissions increase by over 30%.
PharmaGuard – Exceptional processing and product safety
PharmaGuard stands out thanks to the PP film’s high transparency, strong water vapor barrier, excellent push-through performance, stable shrink properties, and wide sealing range – all achieved without the need for additional coatings. The material can also be processed on existing packaging machines with minimal adjustments, and supports inline printing at high speeds. Its uniform thickness distribution during thermoforming ensures a consistent barrier across the entire bottom web – and therefore high product protection. “Inconsistencies affecting packaging reliability are virtually eliminated with PharmaGuard,” emphasizes Thomas Freis.
Moreover, this blister concept is free from phthalates, vinyl, PFAS, and halogens, making it safe for human health. Another reason for pharmaceutical companies to choose PharmaGuard is the absence of nitrosamines.
Informative workshop at Pharmapack
At the upcoming industry event in Paris, Jürgen Bodenmüller from SÜDPACK MEDICA will present this innovative blister concept during a workshop titled “Recycle-Ready PP Solution for Primary Pharma Packaging”. This insightful journey into the sustainable future of the pharmaceutical and packaging industries will get underway on January 22, 2025, from 10:30 to 11:10 a.m. in Room 725 & 726.
